Characteristics of the phenotype of peripheral blood lymphocytes in women with idiopathic recurrent miscarriage in relation to the outcome of pregnancy during immunocytotherapy

1. Carp Howard J.A., ed. Recurrent pregnancy loss: causes, controversies and treatment. Informa UK ltd.; 2007. 290p.

2. Chong P.J., Matzner W.L., Ching W.T. Benefit of leukocyte immunizations? Fertil. Steril. 1993; 59(1): 247-9.

3. Chong P.J., Matzner W.L., Ching W.T. Controversy about immunotherapy. Fertil. Steril. 1993; 59(5): 1138-9.

4. Farquharson R.G., Stephenson M.D., eds. Early pregnancy. Cambridge: University Press; 2012. doi: http://dx.doi.org/10.1017/ CBO9780511777851. Available at: http://ebooks.cambridge.org/

5. Sidelnikova V.M., Sukhikh G.T. Recurrent pregnancy loss: Guidelines for clinicians. Moscow: Medical News Agency; 2011. 516p. (in Russian)

6. Loewendorf A., Nguyen T.A., Yesayan M.N., Kahn D.A. Normal human pregnancy results in maternal immune activation in the periphery and at the uteroplacental interface. PLoS One. 2014; 9(5): e96723.

7. Posiseeva L.V., Malyshkina A.I., Boiko E.L., Sotnikova N.Y., Peretyatko L.P., Fetisova I.N. Rehabilitation of the reproductive health of married couples with recurrent pregnancy loss. Ivanovo: JSC Ivanovo; 2008. 240с. (in Russian)

8. Liang P., Mo M., Li G.G., Yin B., Cai J., Wu T. et al. Comprehensive analysis of peripheral blood lymphocytes in 76 women with recurrent miscarriage before and after lymphocyte immunotherapy. Am. J. Reprod. Immunol. 2012; 68(2): 164-74.

9. Krechetova L.V., Khachatryan N.A., Tetruashvili N.K., Vtorushina V.V., Stepanova E.O., Nikolaeva M.A., Sukhikh G.T. Specific features of peripheral blood lymphocyte phenotype in women with recurrent miscarriage. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2014; (10): 27-32. (in Russian)

10. Krechetova L.V., Tetruashvili N.K., Khachatryan N.A., Vtorushina V.V., Stepanova E.O., Nikolaeva M.A., Sukhikh G.T. Diagnostic value of assessing a peripheral blood lymphocyte phenotype in women with recurrent miscarriage. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2015; (1): 25-31. (in Russian)

11. Krechetova L.V., Stepanova E.O., Nikolaeva M.A., Vtorushina V.V., Golubeva E.L., Khachatryan N.A., Tetruashvili N.K., Sukhikh G.T. Time course of changes in the peripheral blood lymphocyte subpopulation composition of women with recurrent miscarriage during pregravid immunocytotherapy. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2015; (4): 37-43. (in Russian)

12. Krechetova L.V., Tetruashvili N.K., Vtorushina V.V., Stepanova E.O., Nikolaeva M.A., Golubeva E.L., Khachatryan N.A. Time course of changes in the subpopulation composition of peripheral blood lymphocytes in the first trimester of pregnancy in women with recurrent miscarriage during immunocytotherapy. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2015; (6): 59-66. (in Russian)

13. Sharma S. Natural killer cells and regulatory T cells in early pregnancy loss. Int. J. Dev. Biol. 2014; 58(2-4): 219-29.

14. Somerset D.A., Zheng Y., Kilby M.D., Sansom D.M., Drayson M.T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+CD4+ regulatory T-cell subset. Immunology. 2004; 112: 38-43.

15. Santillán I., Lozano I., Illán J., Verdú V., Coca S., Bajo-Arenas J.M., Martinez F. Where and when should natural killer cells be tested in women with repeated implantation failure? J. Reprod. Immunol. 2015; 108: 142-8.

16. Zhao J.X., Zeng Y.Y., Liu Y. Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J. Reprod. Immunol. 2007; 75(2): 71-81.

17. Xiong H., Zhou C., Qi G. Proportional changes of CD4+CD25+Foxp3+ regulatory T cells in maternal peripheral blood during pregnancy and labor at term and preterm. Clin. Invest. Med. 2010; 33(6): E422.

18. Bogdan A., Polgar B., Szekeres-Bartho J. Progesterone induced blocking factor isoforms in normal and failed murine pregnancies. Am. J. Reprod. Immunol. 2014; 71(2): 131-6.

19. Druckmann R., Druckmann M.A. Progesterone and the immunology of pregnancy. J. Steroid Biochem. Mol. Biol. 2005; 97(5): 389-96.

20. Check J.H., Szekeres-Bartho J., O’Shaughnessy A. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation. Am. J. Reprod. Immunol. 1996; 35(3): 277-80.

21. Raghupathy R., Al-Mutawa E., Al-Azemi M., Makhseed M., Azizieh F., Szekeres-Bartho J. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J. Reprod. Immunol. 2009; 80(1-2): 91-9.

22. Kelemen K., Bognar I., Paal M., Szekeres-Bartho J. A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell. Immunol. 1996; 167(1): 129-34.

23. Arck P., Hansen P.J., Mulac Jericevic B., Piccinni M.P., Szekeres-Bartho J. Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am. J. Reprod. Immunol. 2007; 58(3): 268-79.

24. Szekeres-Bartho J., Weill B.J., Mike G., Houssin D., Chaouat G. Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunol. Lett. 1989; 22(4): 259-61.

Received 25.04.2017

Accepted 28.04.2017